Contineum Therapeutics, Inc. Class A Common Stock
NASDAQ:CTNM · NASDAQ Global Select
-$0.39 today
Vol 0.31M · Avg 0.26M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+189.81%
Period High
$16.00
Period Low
$3.73
Latest
$11.94
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Capricor Therapeutics, Inc.
NASDAQ:CAPR
$1.29B
Alto Neuroscience, Inc.
NYSE:ANRO
$779.61M
Candel Therapeutics, Inc.
NASDAQ:CADL
$438.11M
Lexeo Therapeutics, Inc. Common Stock
NASDAQ:LXEO
$389.07M
Kyverna Therapeutics, Inc.
NASDAQ:KYTX
$350.33M
Amarin Corporation plc
NASDAQ:AMRN
$334.44M
Silence Therapeutics plc
NASDAQ:SLN
$324.73M
AC Immune S.A.
NASDAQ:ACIU
$240.19M
Aldeyra Therapeutics, Inc.
NASDAQ:ALDX
$116.42M
Mereo BioPharma Group plc
NASDAQ:MREO
$50.79M
What is the latest CTNM filing?
The latest filing shown is 4 dated Jun 1, 2026.
How many recent filings does CTNM have?
Intrinsic Alpha currently shows 20 recent filings for CTNM.
Explore More
Continue the stock analysis
Jump to another research area for this company.